These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24786128)

  • 1. Renal lipidosis in patients enrolled in a methadone substitution program.
    Porubsky S; Kuppe C; Maier T; Birk HW; Wörnle M; Moeller MJ; Floege J; Gröne HJ
    Arch Pathol Lab Med; 2014 May; 138(5):689-93. PubMed ID: 24786128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First, do no harm: QT interval screening in methadone maintenance treatment.
    Haigney MC
    J Addict Dis; 2011 Oct; 30(4):309-12. PubMed ID: 22026521
    [No Abstract]   [Full Text] [Related]  

  • 3. QT or not QT, that is the question: routine electrocardiograms for individuals in methadone maintenance treatment.
    Stimmel B
    J Addict Dis; 2011 Oct; 30(4):307-8. PubMed ID: 22026520
    [No Abstract]   [Full Text] [Related]  

  • 4. Methadone for Fun Sake… Kidneys Are at Stake!!!
    Chaudhari S; Wankhedkar K; Popis-Matejak B; Baumstein D
    Am J Ther; 2016; 23(4):e1108-9. PubMed ID: 25782567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
    Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
    Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher methadone doses are associated with lower mortality in patients of opioid dependence in Taiwan.
    Liao DL; Chen PC; Chen CH; Hsieh CJ; Huang YF; Shih WY; Cheng JJ
    J Psychiatr Res; 2013 Oct; 47(10):1530-4. PubMed ID: 23880602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular lipidosis as a feature of renal-limited macrophage activation syndrome in a transplanted kidney: a case report.
    Sugisaki K; Uchida T; Iwama S; Okihara M; Akashi I; Kihara Y; Konno O; Kuroda M; Koike J; Iwamoto H; Oda T
    BMC Nephrol; 2023 Nov; 24(1):329. PubMed ID: 37936128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ageing methadone population: A challenge for treating doctors.
    Nagarajan S; Wong A; Greene SL; Koutsogiannis Z
    Aust J Gen Pract; 2019 Mar; 48(3):111-112. PubMed ID: 31256476
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.
    Peles E; Linzy S; Kreek MJ; Adelson M
    J Addict Med; 2013; 7(6):428-34. PubMed ID: 24145160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METODO, a prospective observational study to assess the efficacy and tolerability of methadone in heroin-addicted patients undergoing a methadone maintenance treatment: preliminary results at baseline evaluation.
    D'Egidio PF; Bignamini E; De Vivo E; Leonardi C; Pieri MC; González-Saiz F; Lucchini A;
    Subst Use Misuse; 2013 Dec; 48(14):1530-40. PubMed ID: 23822738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSAT's QT interval screening in methadone report: outrageous fortune or sea of troubles?
    Bart G
    J Addict Dis; 2011 Oct; 30(4):313-7. PubMed ID: 22026522
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychiatric disorders associated with high-dose methadone (>100 mg/d): a retrospective analysis of treated patients].
    Eiden C; Leglise Y; Clarivet B; Blayac JP; Peyrière H
    Therapie; 2012; 67(3):223-30. PubMed ID: 22874488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A; Patil D; Scheinberg K; Blackinton Gale R; Vayalapalli S; Casarella J; Drexler K
    J Addict Dis; 2013; 32(3):244-51. PubMed ID: 24074190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of methadone-induced torsades de pointes with lidocaine.
    Rajpal S; Mundi AS; Reddy PC; Akkus NI
    J La State Med Soc; 2013; 165(6):338-41. PubMed ID: 25073261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study.
    Fareed A; Vayalapalli S; Scheinberg K; Gale R; Casarella J; Drexler K
    Am J Drug Alcohol Abuse; 2013 Jul; 39(4):235-40. PubMed ID: 23808912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glomerular lipidosis].
    Feriozzi S
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study.
    Cousins G; Teljeur C; Motterlini N; McCowan C; Dimitrov BD; Fahey T
    J Subst Abuse Treat; 2011 Oct; 41(3):252-60. PubMed ID: 21696913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology corner. Methadone.
    Lorman WJ
    J Addict Nurs; 2014; 25(4):209-10. PubMed ID: 25514692
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular-associated disease in an addicted population: an observation study.
    Demarie D; Marletta G; Imazio M; Cappa C; Ferro S; Compostino R; De Vivo E; Trinchero R; Bignamini E
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):51-4. PubMed ID: 21135593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.